From: Blockade of ARHGAP11A reverses malignant progress via inactivating Rac1B in hepatocellular carcinoma
Clinicopathological variables | ARHGAP11A mRNA expression | Total | P value | |
---|---|---|---|---|
Low | High | |||
Clinical grades | ||||
 G1/2 | 137 | 95 | 232 | .000 |
 G3/4 | 47 | 87 | 134 | |
Total | 184 | 182 | 366 | Â |
T Stage | ||||
 T1 | 106 | 75 | 181 | .001 |
 T2 | 41 | 53 | 94 | |
 T3/4 | 36 | 57 | 93 | |
Total | 183 | 185 | 368 | Â |
Pathological Stage | ||||
 Stage I | 99 | 72 | 171 | .004 |
 Stage II | 39 | 47 | 86 | |
 Stage III/IV | 36 | 54 | 90 | |
Total | 174 | 173 | 347 | Â |